EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy

Hilal Kalkan, Ester Pagano, Debora Paris iD, Elisabetta Panza iD, Mariarosaria Cuozzo, Claudia Moriello iD, Fabiana Piscitelli iD, Armita Abolghasemi, Elisabetta Gazzerro, Cristoforo Silvestri, Raffaele Capasso iD, Andrea Motta iD und 3 weitere

EMBO Molecular Medicine · 2023

DOI: 10.15252/emmm.202216225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EMBO Molecular Medicine, 2023. Verfasst von Hilal Kalkan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Endocannabinoid Research Group, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Pozzuoli, Italy. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Duchenne Parent Project, Sentinelle Nord.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nothing is known about the potential implication of gut microbiota in skeletal muscle disorders. Here, we provide evidence that fecal microbiota composition along with circulating levels of short‐chain fatty acids (SCFAs) and related metabolites are altered in the mdx mouse model of Duchenne muscular dystrophy (DMD) compared with healthy controls. Supplementation with sodium butyrate (NaB) in mdx mice rescued muscle strength and autophagy, and prevented inflammation associated with excessive endocannabinoid signaling at CB1 receptors to the same extent as deflazacort (DFZ), the standard palliative care for DMD. In LPS‐stimulated C2C12 myoblasts, NaB reduces inflammation, promotes autophagy, and prevents dysregulation of microRNAs targeting the endocannabinoid CB1 receptor gene, in a manner depending on the activation of GPR109A and PPARγ receptors. In sum, we propose a novel disease‐modifying approach in DMD that may have benefits also in other muscular dystrophies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneAnimalsMiceAutophagyDysbiosisEndocannabinoidsInflammationMice, Inbred mdxMuscle, SkeletalIntestines

Stichwörter der Autor:innen

autophagyduchenne muscular dystrophyendocannabinoid systemgut microbiotashort-chain fatty acids

Substanzen

Endocannabinoids

Autor:innen und Institutionen

  • Endocannabinoid Research Group, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Pozzuoli, Italy.
  • Department of Pharmacy, University Federico II of Naples, Italy.
  • Institut Universitaire de Cardiologie et de Pneumologie de Québec and Institut Sur la Nutrition et Les Aliments Fonctionnels, Centre NUTRISS, Université Laval, Quebec City, QC, Canada.
  • Unit of Muscle Research, Experimental and Clinical Research Center Charité Universitätsmedizin and Max Delbrück Research Center, Berlin, Germany.
  • Department of Agricultural Sciences, University of Naples Federico II, Portici, Italy.

ORCID-Profile: Debora Paris, Elisabetta Panza, Claudia Moriello, Fabiana Piscitelli, Raffaele Capasso, Andrea Motta, Roberto Russo, Vincenzo Di Marzo, Fabio Arturo Iannotti

Förderung

  • Duchenne Parent Project
  • Sentinelle Nord

Zitieren

APA

Kalkan, H., Pagano, E., Paris, D., Panza, E., Cuozzo, M., Moriello, C., Piscitelli, F., Abolghasemi, A., Gazzerro, E., Silvestri, C., Capasso, R., Motta, A., Russo, R., Di Marzo, V., & Iannotti, F. A. (2023). Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.202216225

Vancouver

Kalkan H, Pagano E, Paris D, Panza E, Cuozzo M, Moriello C, et al. Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy. EMBO Molecular Medicine. 2023. doi:10.15252/emmm.202216225

BibTeX
@article{Kalkan2023,
  author = {Kalkan, Hilal and Pagano, Ester and Paris, Debora and Panza, Elisabetta and Cuozzo, Mariarosaria and Moriello, Claudia and Piscitelli, Fabiana and Abolghasemi, Armita and Gazzerro, Elisabetta and Silvestri, Cristoforo and Capasso, Raffaele and Motta, Andrea and Russo, Roberto and Di Marzo, Vincenzo and Iannotti, Fabio Arturo},
  title = {Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy},
  journal = {EMBO Molecular Medicine},
  year = {2023},
  doi = {10.15252/emmm.202216225}
}
Kostenlos starten →